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Immunityely evolved not only to maintain cellular and tissue homeostasis but also to
protect cells against microbial attack. This conserved mechanism by which cytoplasmic cargo is delivered to
the endolysosomal system is now recognized as a central player in coordinating the host response to diverse
intracellular pathogens, including viruses. As an endolysosomal delivery system, autophagy functions in the
transfer of viruses from the cytoplasm to the lysosome where they are degraded, in the transfer of viral
nucleic acids to endosomal sensors for the activation of innate immunity, and in the transfer of endogenous
viral antigens to MHC class II compartments for the activation of adaptive immunity. Viruses have, in turn,
evolved different strategies to antagonize, and potentially, to exploit the host autophagic machinery.
Moreover, through mechanisms not yet well understood, autophagy may dampen host innate immune and
inﬂammatory responses to viral infection. This review highlights the roles of autophagy in antiviral
immunity, viral strategies to evade autophagy, and potential negative feedback functions of autophagy in the
host antiviral response.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionAutophagy is a conserved pathway that functions in all eukaryotic
organisms to maintain cellular homeostasis. The autophagy pathway
targets for lysosomal degradation both cellular cytoplasmic constitu-
ents, such as damaged or surplus organelles, proteins and protein
aggregates, as well as microbial invaders, including viruses [1,2].
During autophagy, an isolation membrane wraps portions of cyto-
plasm to form a double-membrane organelle (autophagosome), the
autophagosome undergoes fusion with the endolysosomal system to
form the autolysosome, and degradation of the engulfed material
occurs inside the autolysosome. The ﬁrst description of autophagy-
like structures in virally-infected cells was decades ago; Palade et al.
visualized poliovirus particles inside double-membraned vacuoles
that resembled autophagosomes [3]. However, the signiﬁcance of
autophagy in virus infection, until recent years, has remained elusive.
Recently, there has been an expansion of literature on autophagy and
immunity, which in part, has helped elucidate the diverse functions of
autophagy in virus infections. Although still controversial, the general
concepts are that autophagy may function both as an antiviral
pathway (that degrades viruses) or as a pro-viral pathway (that
helps viruses replicate or exit from cells), as a pathway that facilitates
or prevents viral pathogenesis, and as a pathway that regulates innate
and adaptive immune responses to viral infections (Fig. 1). Moreover,l Center, 5323 Harry Hines
. Levine).
ll rights reserved.the genes that execute autophagy, called autophagy or ATG genes, may
have cellular functions independent of autophagy, raising the
possibility that the effects of some autophagy genes in viral infections
may reﬂect the role of this machinery in alternate cellular processes.
This review will summarize present knowledge and controversies
about the complex relationships between autophagy genes, immunity,
and virus infection.
2. Autophagy and innate immunity in the host antiviral response
2.1. Autophagy in cooperation with innate immunity
When a virus invades a cell, the cell needs to recognize the virus
immediately to evoke initial antiviral responses [4]. As sensors,
pattern recognition receptors (PRRs) recognize viruses and trigger
signaling cascades that induce antiviral mediators such as type I IFNs
and pro-inﬂammatory cytokines. One family of PRRs, the endosomal
Toll-like receptors (TLRs), is reported to have direct links with the
autophagy pathway, at least in certain cultured cells. For example, the
stimulation of TLR7 by single-stranded RNA (ssRNA) induces
autophagy in a mouse macrophage cell line [5] and this autophagy
induction is diminished by knockdown of TLR7, or MyD88, a myeloid
differentiation factor 88 that mediates TLR7 signaling. Thus, since
ssRNA viruses are recognized by TLR7 and TLR7 induces autophagy,
TLR7 likely mediates autophagy induction by this class of viruses.
Furthermore, TLR3, which recognizes dsRNA, a common viral
replication intermediate, also induces autophagy [6]. It is not yet
knownwhether TLRs that recognize other forms of viral nucleic acids,
Fig. 1. Schematic overview of the relationships between autophagy (or autophagy proteins) and viral infection. Adaptive immunity (purple shaded region): Autophagy delivers
endogenously synthesized viral proteins to MHC class II-loading compartments (MIIC), where they are loaded onto MHC class II molecules for presentation to CD4+ T cells.
Cooperation with innate immunity (blue shaded region): After virus infection, dsRNA structures activate the interferon-inducible antiviral molecule, PKR, which induces autophagy.
Virions are engulfed in autophagosomes and degraded within the autolysosome. The HSV-1 virulence protein, ICP34.5, antagonizes both PKR activity and the autophagy protein
Beclin 1 while viral Bcl-2 familymembers antagonize Beclin 1 to suppress autophagy induction. Viral nucleic acids are delivered by autophagosomes to endosomes containing toll like
receptor (TLR7), which induces type 1 interferon (IFN) production. Suppression of innate immunity (pink shaded region): Recognition of viral nucleotides through TLR3, 7 and 9 may
induce NLRP3 activation, which mediates caspase-1 activation. Active caspase-1 processes an IL-1β precursor into a mature cytokine, which is secreted. Atg16l1 blocks this process
and Atg16l1 deletion results in increased IL-1β secretion. The Atg5–Atg12 conjugate suppresses the type I IFN response via retinoic acid-inducible gene I (RIG-I) and IFN-β promoter
stimulator-1 (IPS-I) inhibition. Utilization of autophagy machinery (green shaded region): Poliovirus infection induces double-membraned vesicles that contain autophagy marker
proteins. Viral RNA synthesis occurs in association with these membrane vesicles, but autophagy proteins are not essential for poliovirus replication. Poliovirus may also utilize
autophagosome-like structures to exit from the cell without lysis, via fusion of the double-membraned vesicle with the plasma membrane. Hepatitis C virus (HCV) induces double-
membraned vesicles that contain autophagy markers through activation of the unfolded protein response (UPR) and blocks autophagosomal maturation. The double-membraned
vesicles do not co-localize with HCV proteins, suggesting that HCV is neither targeted for autophagosomal degradation, nor uses autophagosome-like structures for viral replication
or morphogenesis. Autophagy proteins are, however, required for enhanced HCV replication through mechanisms that are not yet deﬁned. Throughout ﬁgure, dotted lines represent
cross-talk that is either speculative or occurs by unknown, and possibly, indirect mechanisms. See text for further details.
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viral nucleic acid sensors, such as the retinoic acid-inducible gene
helicases (RLHs), retinoic acid-inducible gene I (RIG-I), melanoma
differentiation-associated gene-5 (MDA-5), and laboratory of genetics
and physiology 2 (LGP2) [4], function similarly in autophagy
activation. Another important question is whether TLR induction of
autophagy occurs during the context of a natural viral infection invivo; Saitoh et al. recently found that TLR agonists previously shown to
induce autophagy in macrophage cell lines failed to induce autophagy
in primary macrophages [7], suggesting that it may be difﬁcult to
extrapolate from in vitro studies to more physiological contexts.
The potential roles of TLR-mediated autophagy induction during
viral infection are unknown. One speculation is that autophagy
induction by TLRsmay promote the capture and digestion of incoming
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by which TLRs induce autophagy also is not yet clear, but recent
evidence suggests that certain TLR-signaling adaptor molecules may
directly intersect with components of the autophagic machinery. For
example, MyD88 and Trif, two signaling adaptors for TLRs, interact
with the autophagy protein Beclin 1 in a manner that is enhanced by
TLR signaling, and shRNA knockdown of MyD88, Trif, or Beclin 1
inhibits TLR-induced autophagy [6]. The interaction between TLR
signal adaptors and Beclin 1 reduces the binding of Beclin 1 to the
autophagy inhibitor, Bcl-2. Based on these ﬁndings, the authors
postulate that TLR signaling leads to autophagy via adaptor-mediated
recruitment of the autophagy protein, Beclin 1, which is part of the
Class III phosphatidylinositol 3-kinase (PI3K) complex that functions
at the stage of autophagosome membrane nucleation. It is not yet
knownwhether TLR adaptor recruitment activates Beclin 1-associated
Class III PI3K activity, which is necessary for autophagosome
formation, and it is not yet known whether TLR adaptors interact
with any other Atg proteins.
The interaction between TLRs and the autophagy pathway may be
multidirectional. While TLRs likely function in autophagy induction
during viral infection, there is also evidence that the autophagic
machinery may function in the delivery of viral nucleic aids to
endosomal TLRs. In plasmacytoid dendritic cells (pDCs) infected with
vesicular stomatitus virus (VSV) or Sendai virus (SV), it has been
shown that an autophagy protein is required for the delivery of viral
nucleic acids to endosomes for detection by TLR7, and consequent
production of the type I IFN, IFN-α [8]. pDCs that lack Atg5 fail to
secrete IFN-α in response to VSV infection in vitro and in vivo in
reconstituted lethally irradiatedmice suggesting an important role for
Atg5, a critical autophagy protein, in innate immune signaling.
Since Atg5 is reported to have autophagy-independent functions
[9,10], it will be important to determine whether this function of Atg5
is through autophagy or some other pathway. Studies examining the
role of other Atg proteins in type 1 IFN production stimulated by TLRs
may be helpful in this regard. Also, it is not yet known how the
autophagy pathway may speciﬁcally identify and capture VSV, and
potentially other viral nucleic acids, for delivery to endosomal TLR7. A
fascinating related question is how non-self versus self ssRNA may be
targeted by autophagy for endosomal delivery. It is also not known
whether DNA viruses that are recognized by TLR9 can be delivered to
the endosome via autophagy.
One other convergent signal in antiviral immunity and autophagy
regulation is the IFN-inducible gene, double-stranded RNA-dependent
protein kinase (PKR). PKR, a keymediator of the antiviral action of IFN,
was originally discovered in the context of its ability to reverse virus-
induced host translational arrest mediated by eIF2α phosphorylation
[11]. However, it is now known that PKR, as well as other stress-
induced eIF2α kinases, are essential for autophagy induction in
response to viral infection and other forms of cellular stress [12,13].
For example, PKR and the serine phosphorylation site of eIF2α are
required for herpes simplex virus-induced autophagy in mouse
embryonic ﬁbroblasts (MEFs) and primary neurons [13,14], and
PERK, the PKR-like ER kinase is required for autophagy induced by ER
stress in MEFs [15]. The mechanisms by which PKR/eIF2α regulates
autophagy are presently unknown. Nonetheless, studies with herpes
simplex virus type 1 (HSV-1) suggest a potentially important role for
PKR-dependent regulation of autophagy in viral pathogenesis; a mutant
HSV-1 strain that lacks the ability to antagonize the autophagy protein
Beclin 1 is highly neuroattenuated in wild-type mice but has full
virulence in pkr−/−mice [16]. Thus, the autophagy-stimulatory function
of PKRmaybe important inmediating someof its antiviral effects, at least
in HSV-1 encephalitis. Further studies are required to dissect the relative
contributions of translational regulation andautophagy regulation in the
antiviral effects of PKR in other viral infections.
Clearly, many important questions remain regarding the coop-
eration between autophagy and TLRs, RLHs and type I IFN signalingin innate immunity. Nonetheless, the newly discovered links do
suggest critical points of intersection, in terms of TLR-mediated
autophagy induction, autophagy-mediated delivery of viral nucleic
acids to TLRs, and regulation of autophagy by a key antiviral IFN-
inducible molecule. This intersection seems likely to underlie
critical, but as yet, incompletely understood roles of autophagy in
innate antiviral immunity.
2.2. Autophagy in the suppression of innate immunity
Two recent lines of evidence suggest that autophagy may not only
serve to activate innate immunity, but may also serve as a “brake” on
the magnitude of the host innate antiviral response. The ﬁrst line of
evidence stems from observations suggesting that the autophagy
proteins, Atg5 and Atg12, down-regulate another group of PRRs, the
cytoplasmic viral nucleic acid sensors, the RLHs [17]. Jounai et al.
found that type I IFN production is enhanced in Atg5−/− and Atg7−/−
MEFs in response to VSV infection or immunostimulatory RNA. The
increase in type I IFN production in Atg5−/− MEFs is associated with
decreased viral replication; however, it is not yet known whether this
decrease is an indirect result of enhanced IFN production or related to
a more direct role for the autophagic machinery in promoting viral
replication, as has been reported for other RNA viruses (see below).
Interestingly, Jounai et al. also found that the Atg5–Atg12 conjugate
can bind to RIG-I and the IFN-β promoter stimulator 1 (IPS-1), an
adaptor protein, to suppress the activity of RLHs in stimulating type I
IFN production. While these ﬁndings suggest a plausible mechanism
by which the autophagic machinery may suppress innate immune
signaling, i.e. through direct inhibitory interactions with RLHs and
their adaptor proteins, it is not yet known whether this process, or
other, as yet unidentiﬁedmechanisms, may explain the increased type
I IFN production observed in VSV-infected Atg5−/− cells.
A second line of recent evidence suggests that autophagy may also
function as a “brake” on the pro-inﬂammatory response regulated by
nucleotide-binding oligomerization domain (NOD)-like receptor
(NLR) proteins [7]. The NLR protein, cyropryrin/NALP/NLRP3, is
reported to recognize ssRNA and dsRNA in the cytoplasm [18] and
forms a complex known as the inﬂammasome, containing ASC
(apoptosis-associated speck-like protein containing a caspase-activat-
ing and recruitment domain) and caspase-1 that is responsible for the
processing of pro-IL-1β to its mature, secreted form [18,19]. Saitoh et
al. found that hematopoietic cells from mice lacking the autophagy
gene, Atg16l1, have increased production of the pro-inﬂammatory
cytokines, IFN-β and IL-18, following endotoxin stimulation of TLR4
[7]. Although not yet proven, it is reasonable to predict that viral
stimulation of this inﬂammatory signaling pathway may also be
negatively regulated by autophagy. A critical question, both with
respect to autophagy-dependent negative regulation of type I IFN
production and IL-1β production, is whether autophagy functions
primarily as an immunosuppressive pathway that increases host
susceptibility to viral infection, or rather, merely provides negative
feedback to dampen immune/inﬂammatory signaling so as to avoid
excessive and potentially harmful inﬂammatory host responses.
3. Autophagy and adaptive immunity in the host
antiviral response
Autophagy may also be involved in adaptive immunity to viral
infections [20,21]. The initial interest in autophagy and adaptive
immunity was stimulated by the discovery that a majority of peptides
presented by MHC Class II molecules were derived from cytosolic
“self” proteins [22,23]. Paludan et al. were the ﬁrst to use genetic
approaches to demonstrate a role for the autophagy machinery in
MHC class II presentation of an endogenously synthesized viral
antigen [24]. They found that siRNA-mediated silencing of the
autophagy gene, Atg12, inhibits the intracellular processing of the
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EBNA1-speciﬁc CD4+ T cell responses. Subsequently, these authors
showed that in dendritic cells, B cells, and epithelial cells, autophago-
somes are constitutively formed and fuse with multivesicular MHC
class II-loading compartments (MCIIs) [25]. Furthermore, the speciﬁc
targeting of inﬂuenza virus matrix protein to autophagosomes via
fusion to the autophagy protein, LC3, enhances MHC class II
presentation to CD4+ T cells.
Thus, it seems likely that the autophagic delivery of certain
endogenously synthesized viral antigens to MHC class II-loading
compartments functions in adaptive antiviral immunity. A dual role
for autophagosomes in degrading viruses and in the delivery of viral
peptides generated by this degradation process to MHC class II-
loading compartments could represent a very effective “two-pronged”
mode of host antiviral defense. An important question is whether
autophagy also plays a role in the more common exogenous pathway
of MHC class II presentation of viral peptides, in which exogenous
endocytosed antigens are presented to CD4+ T cells. Even in the case
of endogenously synthesized viral antigens, it is not yet clear how
broadly the autophagy pathway is utilized for MHC Class II presenta-
tion; for example, in contrast to EBNA1, two other EBV-encoded
nuclear antigens, EBNA2 and EBNA3C, are not presented by MHC class
II molecules via an autophagy-dependent process [26]. Endogenous
MHC class II presentation has been reported for other viral antigens,
such as hepatitis C virus (HCV) core, inﬂuenza nucleoprotein and
hemagglutinin, and human papillomavirus (HPV) 16 E7, but the
involvement of autophagy has not yet been investigated in these
examples [27–31]. Furthermore, it is not yet clear whether autophagic
delivery of endogenous antigens for activation of adaptive immunity is
important in the context of natural viral infections, as existing studies
have been performed in vitro in cells ectopically expressing viral
proteins or antigens. Regardless of these uncertainties, the prospects
seem promising that the selective targeting of viral antigens to the
autophagosome will signiﬁcantly enhance the efﬁcacy of viral
antigen-based vaccines.
4. Autophagy as a potential antiviral mechanism
The targeting of viral components (proteins or nucleic acids),
assembled virions, or host factors required for viral replication for
degradation via an autophagolysosomal pathway could in theory
function as an innate antiviral mechanism. While it is not yet clear by
whichmechanism(s) autophagy restricts viral replication, two studies
have demonstrated an inhibitory effect of autophagy genes on viral
replication in vivo. One study involves plant infection by tobacco
mosaic virus (TMV), a single-stranded RNA virus [32]. In the Nicotiana
benthamiana plant, pathogen infection induces the hypersensitive
response (HR), which is characterized by programmed cell death that
is restricted to infected cells and prevents pathogen spread. In plants
silenced for autophagy genes, including BECLIN 1, VPS34, ATG3 or
ATG7, TMV infection results in HR cell death that extends beyond the
site of infection. Moreover, there is increased replication of TMV in
infected leaves, suggesting that autophagy-related genes function
both to prevent bystander cell death during the HR response and to
limit virus replication. Another study involves mouse infection with
Sindbis virus, a positive-strand RNA virus of the Togaviridae family
that serves as an animal model of human arthropod-borne encepha-
litis [33]. With virus-driven ectopic neuronal expression of the Beclin
1 autophagy protein, there is decreased animal mortality, decreased
virus-induced neuronal apoptosis, fewer Sindbis virus RNA-positive
cells, and lower CNS viral titers. Although the role of endogenous
autophagy genes in protection against Sindbis virus encephalitis has
not yet been examined, this study demonstrates that enhanced
autophagy can inhibit CNS viral replication.
Together, these studies suggest an evolutionarily conserved role
for autophagy genes as an antiviral mechanism in both plants andmammals. As discussed in more detail below, the impaired
neuronal replication of an HSV-1 mutant virus that cannot
inactivate Beclin 1 further supports this concept [16]. It is not yet
known whether the antiviral effects of autophagy are restricted to
the capture of newly synthesized virion components (as suggested
by studies published to date) or whether viruses can also be
targeted to autophagosomes during cellular entry. Furthermore,
virtually nothing is known about the signals that target viral
proteins to the autophagosome; it will be interesting to examine
whether ubiquitination and the p62/SQSTM1 adaptor protein that
function in “earmarking” misfolded or aggregated cellular proteins
for autophagic degradation [34,35] also function similarly to
earmark viral proteins. It will also be important to examine the
role of viral pathogen-associated molecular patterns and pathogen
recognition receptors in the delivery of viruses to the autophago-
lysosomal system for xenophagic degradation. In the case of
intracellular bacterial infection with Listeria in Drosophila, the
PRR molecule PGRP-LE (analogous to NLR in mammals) was shown
to be important in recognizing a Listeria PAMP, resulting in
autophagy induction and restriction of bacterial survival in primary
hemocytes [36]. Further research is likely to reveal parallel roles for
PAMPS and PRRs in autophagic control of viral replication.
5. Evasion of autophagy by viruses
Since autophagy functions as an innate immune mechanism to
eliminate viruses, it is not surprising that some viruses have evolved
mechanisms to escape host autophagy. Thus far, viruses described to
evade autophagy primarily fall within the double-stranded DNA
viruses of the Herpesviridae family. One α-Herpesviridae family
member, HSV-1 has two strategies to block host cell autophagy,
both of which are mediated by the viral protein, infected cell protein
34.5 (ICP34.5), which is an important viral neurovirulence factor
[37,38]. ICP34.5 both antagonizes PKR-dependent induction of
autophagy and also binds to and inhibits the autophagy protein
Beclin 1 [13,14,16]. A mutant HSV-1 virus lacking the Beclin 1-binding
domain of ICP34.5 fails to inhibit autophagy in neurons and fails to
cause lethal encephalitis in wild-type mice but has restored
neurovirulence in pkr−/− mice [16]. These data indicate that PKR
lies genetically upstream of Beclin 1 in vivo, that Beclin 1-dependent
autophagy is important for protection against HSV-1 encephalitis, and
that viral evasion of Beclin 1-dependent autophagy is important for
viral neurovirulence. It is not yet known whether this role of
autophagy in viral protection and this role of viral evasion of
autophagy in viral virulence is restricted to neuronotropic infections
or also occurs in other cell types and tissues. Since basal autophagy in
the mouse nervous system is critical to ensure protein quality control
and the prevention of neurodegenerative diseases [39,40], autophagy
inhibition by viruses may contribute to neuronal death and organism
mortality via mechanisms that are independent of stimulatory effects
on viral replication. Furthermore, as vital postmitotic cells, non-
cytolytic mechanisms for viral clearance, such as those involving
xenophagy (i.e. autophagic degradation of pathogens), may be
particularly important in antiviral host defense in neurons.
Beclin 1 is also the target of autophagy inhibition by viral Bcl-2-like
proteins encoded by the γ-herpesviruses, including Kaposi's sarcoma-
associated herpesvirus (KSHV) vBcl-2 [41,42] and the murine γ-
herpesvirus 68-encoded protein, M11. At present, it is unknown
whether autophagy evasion by vBcl-2 is important for γ-herpes-
viruses replication and pathogenesis, but it is interesting to note that
these viruses are oncogenic and that Beclin 1 and the autophagy
pathway function in tumor suppression [43]. A member of the β-
Herpesviridae family, human cytomegalovirus (HCMV) can also
down-regulate autophagy [44]; the mechanism by which this occurs
is not yet fully deﬁned but requires viral protein expression and may
involve stimulation of the autophagy inhibitory mTOR signaling
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ICP34.5 or viral Bcl-2 proteins, indicating that each family of
herpesviruses (e.g. the α, β, and γ-herpesviruses) may have evolved
distinct molecular strategies to evade host autophagy.
The common evolutionarily pressure for different families of
herpesviruses to evolve such strategies suggests a fundamental need
for viral evasion of autophagy in the life cycle of herpesviruses.
Further work needs to be done to investigate whether other families
of viruses also possess mechanisms to evade host autophagy, and the
role of such mechanisms in viral pathogenesis. As it is already known
that numerous viruses regulate autophagy signaling pathways, such
as the PKR/eIF2α signaling and the Akt/mTOR signaling pathways
[45,46], it seems likely that viral evasion of autophagy will be
common to many virus families. The speciﬁc strategies that individual
viruses use to disarm host autophagy may represent novel targets for
antiviral therapy.
6. Viral utilization of the autophagic machinery for replication
Although autophagy plays a role in antiviral immunity, somewhat
paradoxically, some viruses may utilize components of the autophagic
machinery for their own beneﬁt. Increasing evidence suggests that
autophagy proteins may have autophagy-independent functions,
including in other membrane trafﬁcking events and immune signal-
ing, and in most cases, it is not yet clear whether the utilization of
components of the autophagic machinery for viral replication
represents a true “subversion” of the autophagy process or alternate
functions of autophagy proteins in membrane dynamics or immune
regulation.
Certain positive-stranded RNA viruses and cytoplasmic DNA
viruses induce the formation of cytoplasmic membranes to facilitate
the replication of their genomes on suchmembranes [47]. The vesicles
which certain positive-stranded RNA viruses induce display some
hallmarks of cellular autophagosomes, including a double-mem-
braned nature and positive staining for the autophagy protein, LC3,
although virus-induced vesicles are generally smaller in diameter
than classical autophagosomes. Early work with poliovirus demon-
strating the association of viral replication complexes with double-
membraned structures [48] stimulated investigations of the role of
autophagy in the life cycle of several different RNA viruses and the
cytoplasmic DNA virus, vaccinia virus. These studies have revealed
certain common themes as well as distinct differences, even within
members of the same virus family, with respect to the utilization of
the autophagy pathway in viral replication.
In the case of HCV, a member of the ﬂaviviridae family, two
independent studies demonstrated that HCV induces the accumula-
tion of autophagosomes (without inducing a complete autophagic
response involving protein degradation) in human hepatocytes
[49,50]. However, in both studies, the authors failed to observe
colocalization of HCV proteins with autophagosomes, indicating that,
unlike poliovirus, HCV replication complexes do not appear to be
associated with autophagosome-like structures. Nonetheless, genetic
knockdown of ER stress signalingmolecules required for HCV-induced
autophagy or of autophagy execution genes, such as LC3 or Atg7,
reduced HCV RNA levels [49]. These data suggest that autophagy
induction (or at least components of the autophagic machinery)
somehow enhances HCV replication through an as-of-yet undeﬁned
mechanism that does not directly involve the utilization of autopha-
gosomes for virion replication or morphogenesis. In light of recent
data (discussed above) indicating that autophagy may participate in
the suppression of innate immune signaling, one unexplored
possibility is that the increased HCV replication observed in
autophagy-deﬁcient cells may be an indirect consequence of
enhanced innate immune signaling. It is tempting to speculate that
HCV, and other viruses that successfully establish persistent infec-
tions, may simultaneously activate autophagy to suppress innateimmune signaling, while simultaneously blocking the maturation of
autophagosomes into autolysosomes that degrade virus. Given the
absence of colocalization between HCV proteins and markers of even
early autophagosomes (i.e. Atg5), it is also likely that HCV possesses a
mechanism to block the initial targeting or sequestration of HCV
proteins by the autophagosome.
Another important emerging theme is that components of the
autophagic machinery may play a role in the exit of non-lytic viruses
from infected cells. In poliovirus-infected cells, siRNA-mediated
knockdown of LC3 and Atg12 markedly inhibits the release of
infectious virus while only minimally affecting viral replication [51],
suggesting that the primary function of poliovirus's utilization of the
autophagic machinery may be for viral release rather than, as
previously speculated, to provide a membrane scaffold for RNA
replication. It is not yet clear whether this function of the autophagic
machinery is conserved for other picornaviruses. In Coxsackie B virus-
infected cells, siRNA against the autophagy genes, Atg7, beclin 1, or
Vps34, does decrease the levels of viral protein expression as well as
extracellular viral titers, but the mechanism by which this occurs has
not yet been explored [52]. Furthermore, in cells infected with human
rhinovirus 2 or Drosophila C virus picornavirus (picorna-like virus),
pharmacological or genetic inhibition of autophagy, respectively, does
not affect viral replication [53,54]. Studies with other virus families
that replicate in association with double-membraned structures,
including the coronavirus, mouse hepatitis virus, and the poxvirus,
vaccinia virus, have failed to reveal alterations in viral replication or
morphogenesis in MEFs lacking Atg5 or in embryonic cells lacking
beclin 1 [55–58].
Taken together, it appears that the components of the autophagic
machinery are utilized to optimize viral yields of certain viruses,
including HCV, Dengue virus, poliovirus, Coxsackie B virus, and
potentially HIV (discussed in more detail below) [49–52,59–62]. The
mechanisms by which this occurs may differ for different classes of
viruses, as there is no evidence to date that ﬂavivirus proteins co-
localize with autophagy proteins whereas poliovirus proteins do co-
localize with autophagy proteins. Therefore, certain picornaviruses
may directly co-apt the autophagic machinery whereas the stimula-
tory effect of autophagy on viral replication may be more indirect for
ﬂavivirus replication. More detailed studies are needed to deﬁne the
precise mechanisms by which components of the autophagic
machinery contribute to, rather than inhibit, viral replication.
Another important related question is whether the observed roles
of certain autophagy proteins in supporting viral replication reﬂects a
role for the autophagy pathway per se, a role for autophagy proteins in
the formation of alternative double-membraned cellular compart-
ments involved in virion morphogenesis, or other as-of-yet undeﬁned
roles. An earlier study with the pestivirus, bovine viral diarrhea virus
(BVDV), provides a provocative example of how an autophagy protein
might beneﬁt ﬂavivirus replication in a manner that is independent of
“classical autophagy” or double-membrane vesicle formation [63]. In
most cases, cytopathogenic (cp) BVDV develops from non-cytopatho-
genic (noncp) BVDV by RNA recombination that can occur between
the noncp BVDV genome and RNAs of either viral or cellular origin. A
cp BVDV was isolated from an animal with lethal disease mucosal
syndrome in which the recombination event that converted noncp
BVDV into cp BVDV involved the insertion of the LC3 autophagy
protein into the viral genome. This insertion induces an additional
cleavage of the viral polyprotein downstream of the LC3-encoded
sequence that is independent of the viral NS3 serine protease and
contributes to the ability of the virus to replicate autonomously
without a helper virus. Although not speciﬁcally investigated, the
incorporation of LC3 presumably functions as a signal for speciﬁc
processing of the viral polyprotein by the LC3-directed, cellular Atg4
protease. Thus, this virus may use a proteolytic event of the autophagy
machinery to process viral protein products to enhance its own
replication. While the pathogenesis strategy of bovine pestivirus is
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ﬁndings observed with viral incorporation of an autophagy protein
to effects of the cellular expressed autophagy protein, this study does
highlight an interesting point. Autophagy proteins have complex
biochemical functions, including the regulation of proteolytic proces-
sing and ubiquitin-like protein conjugations, and these biochemical
functions could potentially directly impact viral replication in an
autophagy-independent manner.
7. Viral utilization of the autophagic machinery for pathogenesis
Recent studies with HIV-1 suggest that this virus may not only
utilize components of the autophagic machinery for replication, but
also utilize the autophagic machinery to induce a central feature of
AIDS pathogenesis, the depletion of uninfected CD4+ T lymphocytes.
Several autophagy-related genes were identiﬁed in a genome-wide
siRNA screen to identify host factors required for efﬁcient HIV-1
replication, including Atg7, Atg8 (GABARAPL2), Atg12 and Atg16L2
[64]. Since the screening was performed in HeLa cells, it will be
important to investigate the role of these and other autophagy genes
in HIV-1 replication in its natural target cells, such as lymphocytes and
macrophages. Whether or not autophagy genes function to promote
HIV-1 replication in natural target cells, there is strong in vitro
evidence that HIV-1 induced bystander CD4+ T cell death requires the
autophagic machinery [60,61]. Espert et al. demonstrated that the
binding of HIV-1 envelope protein to the CXCR4 receptor on
uninfected CD4+ T lymphocytes leads to cell death that is reversed
by pharmacological autophagy inhibition (e.g. treatment with 3-
methyladenine) or siRNA against two autophagy genes, Atg7 and be-
clin 1. Future studies are required to determine whether this HIV-1
envelope protein triggered autophagy gene-dependent cell death
contributes to the progressive decline in CD4+ T cell numbers that
occurs in patients with AIDS.
8. Autophagy as a cytoprotective mechanism during viral infection
In contrast to the role of autophagy genes in mediating cell death
induced by HIV envelope glycoprotein in uninfected lymphocytes,
other studies indicate that autophagy may play an important pro-
survival or cytoprotective role during viral infections. As noted above,
autophagy gene silencing results in extensive programmed cell death
in uninfected bystander cells in tobacco mosaic virus-infected plants
[31]. Thus, autophagy may protect uninfected plant cells against
cytokine pro-death signals that are released during the antiviral
innate immune response. It is tempting to speculate that a similar
scenario may be operative in the brains of primates infected with
simian immunodeﬁciency virus (SIV) or patients infected with HIV-1
where glutamate, TNF-α, and other cytokines are candidate neuro-
toxins [62]. Autophagy in neurons (which are not direct targets of SIV/
HIV-1 infection) may protect these cells against toxic effects of
cytokines released by SIV- or HIV-1 infected microglia. Furthermore,
treatment with TNF-α or glutamate has been reported to reduce
autophagy in neurons, and decreased autophagy (as measured by p62
mRNA expression levels) has been reported in the brains of non-
human primates with SIV encephalitis and of patients with HIV
dementia [62]. Therefore, decreased autophagy may be a mechanism
underlying neurodegeneration in SIV and HIV-1 infection. It is also
possible that neuronal autophagy inhibition by direct viral infection,
in the case of HSV-1 encephalitis, may underlie some of the
permanent neurologic dysfunction that occurs in this disease [65].
Finally, autophagymay also protect against virus-induced cell death in
a cell autonomous fashion; Beclin 1 overexpression reduces Sindbis
virus-induced neuronal apoptosis (as noted above) [32] and pharma-
cological inhibition of autophagy enhances parvovirus B19-induced
erythroid cell death [66]. It is not yet clear how autophagy protects
against virus-induced cell death and in the case of Sindbis virusinfection, it is not known whether this protection against cell death is
merely a consequence of reduced levels of viral replication. None-
theless, taken together, the accumulating evidence suggests that
autophagy may play a critical role in reducing the cytopathology of
both direct cellular targets of infection as well as neighboring cells
that may be susceptible to toxic effects of cytokines released by
virally-infected cells.
9. Conclusion
Throughout evolution, host organisms have developed increas-
ingly complex defense systems against viruses, and in turn, viruses
have evolved sophisticated mechanisms to evade host antiviral
defense mechanisms. Although there are many unresolved questions
regarding the role of autophagy in viral infection, the targeting of
speciﬁc autophagy proteins by viral virulence factors underscores the
likely importance of autophagy as a primordial mechanism of antiviral
immunity. In its most primitive form, autophagy may merely be a
mechanism by which individual cells (or unicellular organisms)
protect themselves in a cell autonomous fashion by “eating” the
viruses that attack them. With the evolution of metazoan organisms
and more complex immune systems, the autophagy pathway proteins
are likely to have acquired several different functions that help protect
against virus infection at the organismal level: they function in the
activation of innate immune signaling; they function in adaptive
immunity; and they may function in protecting bystander cells from
detrimental effects of cytokines released during viral infection. Even
the recently reported role of autophagy proteins in the suppression of
innate immunity may represent an adaptive mechanism that controls
the magnitude of the host immune response during viral infection,
thereby preventing detrimental host inﬂammation. Thus, autophagy
proteins likely have evolved diverse functions to orchestrate an
effective multi-pronged host defense against viral infection. In future
studies, it will be important to more clearly deﬁne the precise
molecular mechanisms by which autophagy proteins function in
antiviral immunity and the precise strategies that viruses use to either
evade or exploit host autophagy proteins for their own beneﬁt. Such
knowledge may empower us to outsmart the viruses that outsmart
the host autophagy pathway.
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